[Therapy of non-small cell lung cancer].
Several regimes can provide clinical answers and longer survival to patients with small cell carcinoma of the lungs who respond to treatment. Moreover there is frequently also suppression of pathological symptoms of the disease in these patients. This situation may develop in almost 30% of patients and treatment is from the psychological aspect consistent with the patients expectations. Toxicity of chemotherapy and resulting morbidity and mortality may be followed up by strict clinical supervision and various types of supporting treatment. This supervision of patients explains probably why administration of planned treatment may be less expensive than palliative care.